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Abstract
Polycystic Ovarian Syndrome (PCOS) is a common reproductive and metabolic disorder. It is considered the 
ovarian manifestation of metabolic syndrome and is a common cause for an ovulatory infertility. PCOS commonly 
coexists with other metabolic manifestations such as Non-alcoholic Fatty Liver Disease (NAFLD) which leads to 
therapeutic challenges especially when infertility is involved. Existing treatment strategies for PCOS have limited 
success, side effects or are costly giving rise to a curiosity in women to seek alternative therapies such as Chinese 
Medicine. Chinese medicine formulae with multiple natural ingredients may have beneficial endocrine, cardio metabolic 
and reproductive effects offering an optimal treatment approach for women with NAFLD, PCOS and infertility.
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Introduction
Polycystic Ovarian Syndrome (PCOS) is a common disorder 
affecting up to 21% of women of childbearing age [1]. Initially thought 
to be primarily a reproductive disorder, recent findings suggest that 
50–80% of women with PCOS are obese and have insulin resistance, 
a hallmark of metabolic syndrome [2]. It therefore seems appropriate 
to consider PCOS as the ovarian manifestation of metabolic syndrome. 
Similarly, Nonalcoholic Fatty Liver Disease (NAFLD) has been defined 
as the hepatic manifestation of metabolic syndrome. Clinically, PCOS 
commonly coexists with NAFLD [3], which further complicates the 
therapeutic approach, especially when infertility is of concern.
Conventional approaches to PCOS with infertility have been well 
documented in the literature [4,5], including lifestyle modifications and 
the use of metformin either alone or in combination with clomiphene, 
gonadotropins, ovarian drilling or assisted reproductive techniques. 
However, there are few studies for management of the complex of 
hyperglycaemia, NAFLD and PCOS with infertility. Alongside this, the 
combination of NAFLD and PCOS impedes treatment with some of the 
chemical pharmacotherapies available when there is liver damage and 
impaired liver function [6]. The clinical features of PCOS associated 
with NAFLD are heterogeneous and vary in intensity. The treatment 
for the combination of NAFLD and PCOS with infertility therefore 
presents a therapeutic challenge. A recent report suggests that women 
with a diagnosis of NAFLD prior to giving birth have increased risks 
for adverse pregnancy outcomes, including gestational diabetes, 
preeclampsia, caesarean section and preterm birth [7]. It is this context 
along with the increase in prevalence of coexisting PCOS and NAFLD 
that often gives rise to a curiosity in women to seek alternative therapies, 
especially for those who are desirous to achieve conception naturally. 
Over the last ten years, this condition has become one of the most 
treated disorders in our Chinese medicine clinic with much success. 
Chinese medicinal herbs have been used for many years to treat 
gynaecological disorders according to Traditional Chinese Medicine 
(TCM) theory. In the last decades, experimental and clinical studies 
have shown that these herbal ingredients could regulate gonadotropin-
releasing hormone to induce ovulation and promote blood flow and 
microcirculation to the ovaries and uterus to improve their function 
[8,9]. Zhang et al. have summarized four randomized controlled trials 
that demonstrated a synergetic effect of CHM on clomiphene for 
PCOS with subfertility [10]. We have also observed that most patients 
with PCOS and NAFLD present with a ‘blood stasis syndrome’ in 
TCM which is related to hyperlipidaemia and a prethrombotic state. 
Therefore, our treatment strategies for PCOS and NAFLD initially 
focuses on ameliorating hyperlipidaemia and decreasing thrombotic 
factors by using herbs such as Radix Salvia miltiorrhizae, Fructus 
Crataegus pinnatifida, Fructus Gardenia florida, Radix Angelicae sinensis 
and Rhizoma Coptis chinensis. 
Herbal medicines, such as Fructus Gardenia florida, Fructus Lycium 
barbarum and Rhizoma Coptis chinensis, have also demonstrated a 
beneficial effect on insulin resistance and glucose intolerance [11-
13]. This is particularly relevant when hyperlipidaemia and NAFLD 
implicates liver damage as the use of drugs such as statins and 
metformin are subsequently cautioned. Given that NAFLD significantly 
contributes to adverse outcomes of pregnancy in women with PCOS, 
Salvia miltiorrhizae and Fructus Gardenia florida are important 
ingredients for PCOS women with NAFLD because the active 
compounds, such as tanshinone IIA and gypenoside, lower serum 
cholesterol and triglycerides and also prevents ectopic fat deposition 
in the liver [14]. Oxidative stress plays a role in both liver damage 
and ovarian dysfunction in NAFLD and PCOS respectively [15]. 
Naturally occurring compounds in the formulae, such as berberine 
and polysaccharides, improve clinical outcomes which may be through 
their antioxidant activity [16,17]. 
Furthermore, as herbal formulae contain many different ingredients, 
the effect is often multi-targeted. In my clinical practice it has become 
evident that treating metabolic manifestations simultaneously achieves 
results more quickly than simply targeting one aspect, in the way that 
monotherapies operate. Chinese medicine formulae with multiple 
natural ingredients is capable of producing beneficial endocrine, 
cardiometabolic, and reproductive effects offering an optimal treatment 
approach for women with NAFLD, PCOS and infertility. Additionally 
herbal medicines have fewer side effects compared to standard drug 
therapies. Despite these benefits, most studies for PCOS are small, 
nonrandomized or uncontrolled and there is no clinical study reported 
Citation: Qu X (2015) Natural Approach to Coexisting Non-alcoholic Fatty Liver Disease and Polycystic Ovarian Syndrome. Endocrinol Metab Synd 
4: 182. doi:10.4172/2161-1017.1000182
Page 2 of 2
Endocrinol Metab Synd
ISSN: 2161-1017 EMS, an open access journal Volume 4 • Issue 3 • 1000182
6. Kinnman N, Hultcrantz R (2001) Lipid lowering medication and hepatotoxicity. 
Intern Med 250: 183-185. 
7. Hagström H, Höijer J, Ludvigsson J.F, Bottai M, Ekbom A,et al. (2015) Adverse 
outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver 
Int, doi: 10.1111/liv.12902. [Epub ahead of print].
8. Reid K, Stuart K (2011) Efficacy of Traditional Chinese Herbal medicine in the 
management of female infertility: a systematic review. Complement Ther Med 
19: 319-331. 
9.  Huang S.T, Chen A.P (2008) Traditional Chinese medicine and infertility. Curr 
Opin Obstet Gynecol 20: 211-215.
10. Zhang J, Li T, Zhou L, Tang L, Xu L, et al. (2010) Chinese herbal medicine for 
subfertile women with polycystic ovarian syndrome. Cochrane Database Syst 
Rev 8: 1-45.
11. Ji W, Gong BQ (2008) Hypolipidemic activity and mechanism of purified herbal 
extract of Salvia miltiorrhiza in hyperlipidemic rats. J Ethnopharmacol 119: 291-
298
12. Tan Y, Kamal MA, Wang ZZ, Seale JP, Qu X, et al. (2011) Chinese herbal 
extracts (SK0506) as a potential candidate for the therapy of metabolic 
syndrome. Clin Sci 120: 297-305
13. Li Y, Ma H, Zhang Y, Kuang H, Ng E, et al. (2013) Effect of berberine on insulin 
resistance in women with polycystic ovary syndrome: study protocol for a 
randomized multicenter controlled trial. Trials, 14: 226.
14. Tan Y, Lao W, Xiao L, Seale J, Qu X, et al. (2013) Managing the Combination 
of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese 
Herbal Extracts in High-Fat-Diet Fed Rats. Evid Based Complement 2013: 
1-10.
15. Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I (2012) Oxidative status and its 
relation with insulin resistance in young non-obese women with polycystic 
ovary syndrome. J Endocrinol Invest 35: 317-321. 
16. Jang MH, Kim HY, Kang KS, Yokozawa T, Park JH (2009) Hydroxyl radical 
scavenging activities of isoquinoline alkaloids isolated from Coptis chinensis. 
Arch Pharm Res 32: 341-345.
17. Luo Q, Cui X, Yan J, Yang M, Liu J, et al. (2011) Antagonistic effects of Lycium 
barbarum polysaccharides on the impaired reproductive system of male rats 
induced by local subchronic exposure to 60Co-γ irradiation. Phytother Res 25: 
694-701.
for CHM treatment for the combination of NAFLD and PCOS with 
infertility. This case report presents the use of CHM to target multiple 
abnormalities, firstly focusing on hyperlipidaemia and impaired liver 
function while inducing menstruation for amenorrhea and subsequently 
shifting to focus on improving ovarian function and fertility. Although 
the evidence is limited by one case, successful treatment with CHM 
for this case highlights the potential of natural therapy to manage 
coexisting NAFLD and PCOS cohesively whilst promoting fertility. 
In summary, co-existing NAFLD and PCOS with infertility presents 
a therapeutic challenge for both pharmaceutical medication and natural 
therapy. A uniform treatment for this complex metabolic, endocrinal and 
reproductive disorder does not exist. To achieve successful conception 
and reduce adverse outcomes of pregnancy, the best-tailored treatment 
with CHM should be applied after an accurate evaluation of patients’ 
characteristics. Meanwhile, randomized and controlled multicenter 
trials should be performed to establish evidence-based CHM therapy 
for the treatment of NAFLD and PCOS with infertility. 
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